Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients
- Status
- UNKNOWN
- Phase
- NA
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
- Status
- COMPLETED
- Phase
- NA
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC
- Status
- COMPLETED
- Phase
- PHASE4
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
HR Combined With FOLFOX4 for HCC With PVTT
- Status
- UNKNOWN
- Phase
- PHASE2